aap Implantate Stock
aap Implantate AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- Germany
- CEO
- Rubino Di Girolamo
- Employees
- 105
- Market cap
- €21 M
- IPO
- 11/05/1999
- Web
- www.aap.de
Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company was founded in 1990 and maintains its corporate headquarters in Berlin, Germany. Its market presence spans across Germany, the United States, and…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
aap Implantate stock: price history
1D
-3.3%
1W
-5.8%
1M
-12.6%
6M
-14.1%
YTD
+2.8%
1Y
-7.0%
2Y
-38.1%
5Y
-59.2%
10Y
-87.3%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~27% stronger price swings than usual
Ask the agents about aap Implantate
aap Implantate stock metrics
P/E
-7.49
P/B
2.58
EV/EBITDA
-30.88
RETURN ON EQUITY
-6.9%
NET MARGIN
-17.9%
DEBT/EQUITY
0.49
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
65.3%
FLOAT SHARES
9,608,244
AVG. DAILY VOLUME (30D)
1,179
Dividends & Stock splits
Comparable stocks
Frequently asked questions about aap Implantate stock
What does aap Implantate do?
aap Implantate AG is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Germany.
The CEO is Rubino Di Girolamo, the company employs around 105 people.
The IPO was on 11/05/1999; the stock trades on XETRA under the ticker AAQ1.DE.
When does aap Implantate report next?
Around past earnings, price swings were roughly 27% stronger than usual.
Does aap Implantate pay a dividend?
No, aap Implantate currently does not pay a dividend.
Which stocks are comparable to aap Implantate?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Merck, Siemens Healthineers and Bayer Aktiengesellschaft.
How can I get aap Implantate stock analyzed?
Clicking "Analyze stock" lets five strategies assess aap Implantate against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.